CUV:ASX
Clinuvel Pharmaceuticals Ltd
A$7.15
arrow_downward
-1.24%(-0.090) 1D
Nov 20, 4:10:07 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CUV...
Open
A$7.18
High
A$7.22
Low
A$7.07
Mkt. cap
360.98M
Avg. vol.
158.22K
Volume
97.17K
Dividend
0.70%
Quarterly dividend
A$0.01
Ex-dividend date
Sep 3, 2026
P/E ratio
10.70
52-wk high
A$13.48
52-wk low
A$6.62
EPS
A$0.67
Shares outstanding
50.49M
No. of employees
16
Open
A$7.18
High
A$7.22
Low
A$7.07
Mkt. cap
360.98M
Avg. vol.
158.22K
Volume
97.17K
Dividend
0.70%
Quarterly dividend
A$0.01
Ex-dividend date
Sep 3, 2026
P/E ratio
10.70
52-wk high
A$13.48
52-wk low
A$6.62
EPS
A$0.67
Shares outstanding
50.49M
No. of employees
16
News stories
From web sources and news partners
Fortune
·
59 minutes ago
Stock market correction? This chief investment officer sees the S&P 500 soaring 45% to 10,000
Nacionale
·
5 hours ago
Is the S&P 500 in a bear market, and will it rally? No, it's in a correction, 11.6% below its record
Yahoo Finance
·
2 hours ago
In the Last Tech Bust, the S&P 500 Lost Money for a Decade. History Says Stocks With the Highest Yields Gained 5.4% a Year.
Beinsure
·
7 hours ago
Vanguard S&P 500 ETF: How investing in VOO could build a $1 mn portfolio
About Clinuvel Pharmaceuticals Ltd
CEOPhilippe J. Wolgen
Employees16
Founded1987
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteclinuvel.com